Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 29, 2021 3:01 PM 4 min read

Mid-Afternoon Market Update: US Stocks Mostly Flat; DiaMedica Therapeutics Shares Plunge

by Lisa Levin Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Toward the end of trading Tuesday, the Dow traded up 0.04% to 34,295.41 while the NASDAQ rose 0.13% to 14,518.98. The S&P traded flat at 4,290.65.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,640,570 cases with around 604,110 deaths. India confirmed a total of at least 30,316,890 cases and 397,630 deaths, while Brazil reported over 18,448,400 COVID-19 cases with 514,090 deaths. In total, there were at least 181,437,540 cases of COVID-19 worldwide with more than 3,929,850 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Information technology shares jumped by 0.6% on Tuesday. Meanwhile, top gainers in the sector included DoubleVerify Holdings, Inc. (NYSE:DV), up 9%, and SGOCO Group, Ltd. (NASDAQ:SGOC), up 11%.


In trading on Tuesday, utilities shares fell 1.3%.


Top Headline

FactSet Research Systems Inc. (NYSE:FDS) reported downbeat earnings for its third quarter, while sales exceeded views.

FactSet Research reported quarterly adjusted earnings of $2.72 per share, missing analysts’ estimates of $2.74 per share. The company’s quarterly sales came in at $399.60 million, versus analysts’ expectations of $397.92 million.

FactSet said it sees FY21 adjusted EPS of $10.75-$11.15, versus analysts’ estimates of $11.14. The company projects FY21 sales of $1.57 billion-$1.585 billion, versus expectations of $1.58 billion.


Equities Trading UP


Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) shares shot up 109% to $26.31 after the company announced positive results from its Phase 1b clinical trial of CVL-231 in adult patients with schizophrenia. CVL-231 was generally well-tolerated, and discontinuation rates were similar between CVL-231 and placebo in the six weeks of dosing, at 22% each.


Shares of Marin Software Incorporated (NASDAQ:MRIN) got a boost, shooting 72% to $12.88 after jumping around 97% on Monday. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.


Auddia Inc. (NASDAQ:AUUD) shares were also up, gaining 24% to $7.28 after the company announced the release and national launch of its flagship Auddia app ahead of schedule.

Check out these big movers of the day


Equities Trading DOWN

Better Choice Company Inc (NYSE:BTTR) shares tumbled 39% to $4.49 after the company reported the pricing of its underwritten public offering of 8,000,000 shares at $5.00 per share.

MediWound Ltd. (NASDAQ:MDWD) was down, falling 26% to $4.15. Vericel’s development partner, MediWound, received a complete response letter from FDA regarding the NexoBrid application seeking approval for eschar removal in adults with deep partial-thickness or full-thickness burns.


Commodities


In commodity news, oil traded up 0.2% to $73.07, while gold traded down 1.1% to $1,762.00.


Silver traded down 1.4% Tuesday to $25.845 while copper fell 0.4% to $4.2590.


Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 0.31%, the Spanish Ibex Index rose 0.02% and the German DAX 30 gained 0.88%. Meanwhile, the London’s FTSE 100 rose 0.21%, French CAC 40 gained 0.14% and Italy’s FTSE MIB gained 0.52%.

Spain's consumer price inflation rate fell to 2.6% year-over-year in June from 2.7% a month ago, while retail sales climbed 19.6% from a year ago in May. French consumer confidence rose to 102 in June from 98 in the prior month.

Annual house price growth in the UK increased to 13.4% in June. Consumer credit in the UK rose by GBP 0.28 billion in May, while the country’s factories produced 54,962 cars during May compared to 5,314 in the year-ago period.


Economics


The S&P CoreLogic Case-Shiller 20-city home price index surged 14.9% in April versus a 13.4% rise in the earlier month.


The FHFA house price index rose 1.8% in April.


The Conference Board’s consumer confidence index jumped to 127.3 in June from previous reading of 120.


The American Petroleum Institute’s report on crude oil stocks is scheduled for release at 4:30 p.m. ET.


Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesGlobalIntraday UpdateMarketsMid-Afternoon Market Update
AUUD Logo
AUUDAuddia Inc
$0.79900.08%
Overview
DMAC Logo
DMACDiaMedica Therapeutics Inc
$8.21-1.79%
DV Logo
DVDoubleVerify Holdings Inc
$9.851.03%
FDS Logo
FDSFactSet Research Systems Inc
$204.81-%
MDWD Logo
MDWDMediWound Ltd
$17.952.05%

Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) were down 33% to $4.80 after the company announced interim results from its Phase 2 REDUX trial of DM199 in chronic kidney disease. DM199, the company noted, is demonstrating clinically meaningful improvements in kidney function in Cohorts 1 and 2, as measured by a simultaneously stabilizing estimated glomerular filtration rate and decreasing urine albumin-to-creatinine ratio.

AUUD Logo
AUUDAuddia Inc
$0.79900.08%
Overview
DMAC Logo
DMACDiaMedica Therapeutics Inc
$8.21-1.79%
DV Logo
DVDoubleVerify Holdings Inc
$9.851.03%
FDS Logo
FDSFactSet Research Systems Inc
$204.81-%
MDWD Logo
MDWDMediWound Ltd
$17.952.05%
Comments
Loading...